Although the disease is now treatable, the emergence of drug-resistant strains could complicate care. And millions of inactive cases could help fuel a surge.

Nausea is significantly more frequently reported by patients treated with TMC207 in the MDR-TB trial. Diarrhea, arthralgia, dizziness, hyperuricemia and eye disorders are more frequent ...

After being hospitalised and released multiple times, Raul Carlos was again admitted to Beira Central Hospital, this time in ...

Tuberculosis surveillance and monitoring report, released today by the European Centre for Disease Prevention and Control ...

especially from Ukraine (with a relatively higher incidence of MDR-TB),” Gandhi explained. Could TB spread to the United ...

Learn about the primary ways tuberculosis spreads through airborne transmission, high-risk settings, and effective prevention ...

Mumbai's efforts to combat multi-drug-resistant TB are showing promising results, with cure rates doubling to 80% in eight ...

Berhampur: The state govt has rolled out BPaLM, a shorter duration new treatment regimen for multi-drug resistant ...

Infectious disease specialists note next-generation sequencing as game changer in TB detection: Nandita Vijayasimha, Bengaluru Tuesday, April 8, 2025, 08:00 Hrs [IST] Infectious d ...

The target of ending the global TB epidemic by 2035 is achievable, Cimas Health Group doctor Philip Manema believes, if there ...